Organism name | Papaver somniferum |
---|---|
Genus | Papaver |
Family | Papaveraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Papaver somniferum |
---|---|
Linked NCBI taxonomy ID | 3469 |
Linked level | species |
Family in NCBI taxonomy | Papaveraceae |
---|---|
ID | 3465 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005411
![]() |
Quercetin 3-gentiobioside
|
CHEMBL1097317
|
C088177
|
No. 1 | No. 15 |
![]() |
||
C00026087
![]() |
Cheilanthifoline
/ (-)-Cheilanthifoline |
No. 37 | No. 4 |
![]() |
||||
C00015402
![]() |
alpha-Thebaol
/ 3,6-Dimethoxy-4-hydroxyphenanthrene |
No. 104 | No. 27 |
![]() |
||||
C00015423
![]() |
3,7-Dimethoxy-5-hydroxyphenanthrene
|
No. 104 | No. 27 |
![]() |
||||
C00034613
![]() |
Norcoclaurine
/ (S)-(-)-Higenamine |
CHEMBL19344
CHEMBL501778 CHEMBL470491 |
2 / 2 / 0 | No. 253 | No. 4 |
![]() |
||
C00001917
![]() |
Sanguinarine
/ Pseudochelerythrine |
CHEMBL417799
|
C005705
|
55 / 55 / 77 | 23 / 6 | No. 254 | No. 4 |
![]() |
C00024663
![]() |
Sanguinarin
/ Sanguinarine / Sanguinarium / Pseudochelerythrine |
CHEMBL417799
|
C005705
|
55 / 55 / 77 | 23 / 6 | No. 254 | No. 4 |
![]() |
C00001875
![]() |
Tritopin
/ Tritopine / Laudanidine / (-)-Laudanidine |
CHEMBL251625
CHEMBL1425007 |
2 / 0 / 0 | No. 345 | No. 4 |
![]() |
||
C00001876
![]() |
Laudanosine
/ L-Laudanosine / O-Methylcodamine / L-(+)-Laudanosine |
CHEMBL1407
CHEMBL519894 CHEMBL1613 |
C001522
|
18 / 26 / 21 | 0 / 1 | No. 345 | No. 4 |
![]() |
C00028453
![]() |
Laudanine
|
CHEMBL251625
CHEMBL1425007 |
2 / 0 / 0 | No. 345 | No. 4 |
![]() |
||
C00001910
![]() |
Reticuline
/ (+)-Reticuline |
CHEMBL235212
CHEMBL401501 CHEMBL464734 |
C003298
|
1 / 0 / 0 | No. 345 | No. 4 |
![]() |
|
C00001916
![]() |
Salutaridine
/ (+)-Salutaridine |
CHEMBL402782
CHEMBL404097 |
C009270
|
3 / 4 / 2 | No. 426 | No. 4 |
![]() |
|
C00001891
![]() |
Noscapine
/ alpha-Narcotine / O-Methylnarcotoline |
CHEMBL364713
CHEMBL402487 CHEMBL1403892 CHEMBL1570261 CHEMBL1623561 |
D009665
|
105 / 43 / 42 | 11 / 5 | No. 605 | No. 4 |
![]() |
C00001892
![]() |
Narcotoline
|
C059402
|
No. 605 | No. 4 |
![]() |
|||
C00001906
![]() |
Fumarin
/ Biflorine / Protopine / Fumarine / Corydinine |
CHEMBL453019
|
C009093
|
5 / 5 / 4 | 2 / 0 | No. 820 | No. 4 |
![]() |
C00027332
![]() |
Cryptopin
/ Cryptopine / Kryptopine / Kryptocavin / Cryptocavine |
CHEMBL1339015
|
C007159
|
6 / 5 / 8 | No. 820 | No. 4 |
![]() |
|
C00000615
![]() |
Caffeic acid
|
CHEMBL145
CHEMBL1320034 |
68 / 64 / 63 | No. 904 | No. 6 |
![]() |
||
C00001408
![]() |
Dopamine
|
CHEMBL59
|
D004298
|
69 / 40 / 56 | 51 / 52 | No. 1114 | No. 6 |
![]() |
C00001899
![]() |
Papaverine
|
CHEMBL19224
|
D010208
|
121 / 66 / 52 | 5 / 50 | No. 1165 | No. 4 |
![]() |
C00027467
![]() |
Papavarine
|
CHEMBL19224
|
121 / 66 / 52 | No. 1165 | No. 4 |
![]() |
||
C00001893
![]() |
Neopine
|
No. 1983 | No. 4 |
![]() |
||||
C00001924
![]() |
Thebaine
/ (-)-Thebaine / Paramorphine |
CHEMBL403893
CHEMBL1318110 |
D013797
|
4 / 0 / 0 | No. 1983 | No. 4 |
![]() |
|
C00001890
![]() |
Narceine
|
CHEMBL486305
|
No. 2202 | No. 4 |
![]() |
|||
C00028646
![]() |
Narceinone
|
No. 2202 | No. 4 |
![]() |
||||
C00001915
![]() |
Salsolinol
/ (-)-Salsolinol |
CHEMBL416732
CHEMBL1193327 CHEMBL1195032 |
14 / 11 / 9 | No. 2962 | No. 4 |
![]() |
||
C00000118
![]() |
N-Malonyltryptophan
|
No. 2986 |
![]() |
|||||
C00000117
![]() |
Indole-3-acetyl-L-aspartic acid
|
C026984
|
No. 2986 |
![]() |
||||
C00001889
![]() |
Morphine
/ (-)-Morphine |
CHEMBL70
CHEMBL1888905 CHEMBL2133708 CHEMBL2139208 |
D009020
|
32 / 17 / 11 | 71 / 199 | No. 4235 | No. 4 |
![]() |
C00001837
![]() |
Codeine
/ (-)-Codeine |
CHEMBL485
CHEMBL22662 CHEMBL612012 CHEMBL1907378 |
D003061
|
16 / 12 / 6 | 6 / 66 | No. 4235 | No. 4 |
![]() |
C00027603
![]() |
6-Oxocodeine
/ (-)-Codeinone |
CHEMBL163490
CHEMBL257627 |
C046414
|
1 / 0 / 0 | 5 / 2 | No. 4235 | No. 4 |
![]() |
C00027193
![]() |
Bismorphine B
|
No. 7388 |
![]() |
|||||
C00034467
![]() |
Codeine N-oxide
|
No. 8425 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000615 C00001408 C00001837 C00001876 C00001889 C00001891 C00001899 C00001906 C00001915 C00001917 C00024663 C00027332 C00027467 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000615 C00001408 C00001876 C00001889 C00001891 C00001899 C00001906 C00001915 C00001917 C00024663 C00027332 C00027467 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000615 C00001408 C00001876 C00001889 C00001891 C00001899 C00001906 C00001915 C00001917 C00024663 C00027467 | 0 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000615 C00001408 C00001876 C00001889 C00001891 C00001899 C00001915 C00001917 C00024663 C00027467 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000615 C00001408 C00001876 C00001889 C00001891 C00001899 C00001915 C00001917 C00024663 C00027467 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001837 C00001889 C00001891 C00001899 C00001910 C00001916 C00001924 C00027467 C00027603 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000615 C00001408 C00001876 C00001906 C00001915 C00001917 C00024663 C00027332 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000615 C00001408 C00001891 C00001899 C00001915 C00001917 C00024663 C00027467 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000615 C00001408 C00001876 C00001891 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001876 C00001889 C00001891 C00001899 C00001917 C00024663 C00027332 C00027467 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000615 C00001408 C00001875 C00001876 C00001889 C00001917 C00024663 C00028453 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000615 C00001408 C00001876 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000615 C00001408 C00001899 C00001915 C00001917 C00024663 C00027467 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000615 C00001899 C00001906 C00001915 C00001917 C00024663 C00027467 | 3 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000615 C00001408 C00001876 C00001915 C00001917 C00024663 | 3 / 3 |
P02545 | Prelamin-A/C | Unclassified protein | C00000615 C00001876 C00001899 C00001917 C00024663 C00027467 | 11 / 10 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001408 C00001891 C00001899 C00001915 C00027467 C00034613 | 2 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001408 C00001891 C00001899 C00001915 C00027467 C00034613 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001408 C00001891 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001408 C00001876 C00001889 C00001917 C00001924 C00024663 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000615 C00001837 C00001889 C00001891 C00001899 C00027467 | 2 / 2 |
O00255 | Menin | Unclassified protein | C00000615 C00001891 C00001917 C00024663 C00027332 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000615 C00001891 C00001917 C00024663 C00027332 | 1 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000615 C00001408 C00001891 C00001899 C00027467 | 1 / 2 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001891 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001837 C00001889 C00001891 C00001899 C00027467 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001837 C00001889 C00001891 C00001899 C00027467 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001408 C00001899 C00001917 C00024663 C00027467 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001408 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000615 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001408 C00001889 C00001891 C00001899 C00027467 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00001891 C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001408 C00001837 C00001889 C00001899 C00027467 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001875 C00001889 C00001891 C00001924 C00028453 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001408 C00001891 C00001915 C00001917 C00024663 | 1 / 1 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000615 C00001891 C00001899 C00027467 | 2 / 2 |
P03372 | Estrogen receptor | NR3A1 | C00000615 C00001891 C00001899 C00027467 | 1 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001876 C00001891 C00001917 C00024663 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001408 C00001891 C00001899 C00027467 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001408 C00001891 C00001899 C00027467 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000615 C00001408 C00001899 C00027467 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001408 C00001891 C00001899 C00027467 | 1 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001408 C00001891 C00001899 C00027467 | 1 / 1 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001899 C00001917 C00024663 C00027467 | 2 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000615 C00001408 C00001917 C00024663 | 4 / 3 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001889 C00001891 C00001899 C00027467 | 1 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001408 C00001891 C00001899 C00027467 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00000615 C00001891 C00001899 C00027467 | 0 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000615 C00001891 C00001899 C00027467 | 0 / 3 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001408 C00001891 C00001899 C00027467 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001889 C00001891 C00001899 C00027467 | 1 / 1 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001876 C00001891 C00001899 C00027467 | 2 / 2 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | C00001837 C00001889 C00001899 C00027467 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001408 C00001891 C00001899 C00027467 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001876 C00001891 C00001899 C00027467 | 1 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001408 C00001891 C00001899 C00027467 | 0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | C00001837 C00001889 C00001899 C00027467 | 2 / 2 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000615 C00001891 C00001899 C00027467 | 0 / 0 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | C00001837 C00001889 C00001899 C00027467 | 3 / 2 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001899 C00001917 C00024663 C00027467 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00001899 C00001917 C00024663 C00027467 | 4 / 1 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001408 C00001891 C00001899 C00027467 | 2 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001408 C00001891 C00001899 C00027467 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000615 C00001891 C00001899 C00027467 | 1 / 8 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001891 C00001899 C00027467 | 0 / 1 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00001408 C00001837 C00001889 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001891 C00001899 C00027467 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001408 C00001917 C00024663 | 7 / 37 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001891 C00001899 C00027467 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001891 C00001899 C00027467 | 1 / 1 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001891 C00001899 C00027467 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001891 C00001899 C00027467 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000615 C00001408 C00001915 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001891 C00001899 C00027467 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001891 C00001899 C00027467 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001891 C00001899 C00027467 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001408 C00001917 C00024663 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00001891 C00001899 C00027467 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000615 C00001917 C00024663 | 2 / 2 |
P29466 | Caspase-1 | C14 | C00001891 C00001899 C00027467 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001891 C00001899 C00027467 | 1 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001891 C00001899 C00027467 | 2 / 1 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001891 C00001899 C00027467 | 1 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00001408 C00001837 C00001889 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001891 C00001899 C00027467 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001891 C00001899 C00027467 | 0 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001408 C00001837 C00001889 | 3 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001408 C00001917 C00024663 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001891 C00001899 C00027467 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001891 C00001899 C00027467 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001891 C00001899 C00027467 | 1 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001891 C00001899 C00027467 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001891 C00001899 C00027467 | 3 / 0 |
P08246 | Neutrophil elastase | S1A | C00001891 C00001899 C00027467 | 2 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001891 C00001899 C00027467 | 1 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001891 C00001899 C00027467 | 5 / 9 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001408 C00001837 C00001889 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001891 C00001917 C00024663 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001891 C00001899 C00027467 | 2 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001876 C00001917 C00024663 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001891 C00001899 C00027467 | 0 / 0 |
Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | C00001917 C00024663 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001917 C00024663 | 2 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00001917 C00024663 | 0 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00001917 C00024663 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00000615 C00001408 | 4 / 2 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00001917 C00024663 | 1 / 0 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00001408 C00001891 | 0 / 0 |
Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | C00001899 C00027467 | 0 / 0 |
P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00001917 C00024663 | 0 / 0 |
Q9Y233 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | PDE_10A | C00001899 C00027467 | 0 / 0 |
Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | C00001899 C00027467 | 0 / 0 |
Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | C00001899 C00027467 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000615 C00001408 | 0 / 0 |
P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | C00001899 C00027467 | 0 / 0 |
Q01064 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | PDE_1B | C00001899 C00027467 | 0 / 0 |
P54750 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | PDE_1A | C00001899 C00027467 | 0 / 0 |
Q14123 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | PDE_1C | C00001899 C00027467 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001917 C00024663 | 1 / 4 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001917 C00024663 | 0 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000615 C00001408 | 1 / 1 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00001917 C00024663 | 1 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000615 C00001408 | 0 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000615 C00001408 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000615 C00001408 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001917 C00024663 | 2 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000615 C00001408 | 1 / 1 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000615 C00001408 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00001917 C00024663 | 1 / 1 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00001917 C00024663 | 1 / 1 |
O00408 | cGMP-dependent 3',5'-cyclic phosphodiesterase | PDE_2A | C00001899 C00027467 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001917 C00024663 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000615 C00001408 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00001837 C00001889 | 0 / 0 |
Q92934 | Bcl2 antagonist of cell death | Other cytosolic protein | C00001917 C00024663 | 0 / 0 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00001837 C00001889 | 0 / 0 |
Q13370 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | PDE_3B | C00001899 C00027467 | 0 / 0 |
Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE_3A | C00001899 C00027467 | 0 / 0 |
Q92793 | CREB-binding protein | Enzyme | C00001899 C00027467 | 1 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000615 C00001408 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000615 C00001408 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001917 C00024663 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000615 C00001408 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001917 C00024663 | 2 / 3 |
O14924 | Regulator of G-protein signaling 12 | Unclassified protein | C00001917 C00024663 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00001917 C00024663 | 4 / 2 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001917 C00024663 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00001408 C00001889 | 5 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00001837 C00001889 | 1 / 0 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000615 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000615 | 1 / 0 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00000615 | 0 / 0 |
P21918 | D(1B) dopamine receptor | Dopamine receptor | C00001408 | 1 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000615 | 3 / 1 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000615 | 1 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000615 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000615 | 1 / 1 |
O95622 | Adenylate cyclase type 5 | Enzyme | C00001408 | 1 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00000615 | 1 / 1 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001408 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00001889 | 0 / 0 |
O43704 | Sulfotransferase family cytosolic 1B member 1 | Enzyme | C00001408 | 0 / 0 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00001408 | 0 / 0 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000615 | 0 / 0 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00000615 | 4 / 2 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000615 | 0 / 0 |
P36537 | UDP-glucuronosyltransferase 2B10 | Enzyme | C00001889 | 0 / 0 |
P49286 | Melatonin receptor type 1B | Melatonin receptor | C00001408 | 0 / 1 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00001889 | 0 / 0 |
Q86VL8 | Multidrug and toxin extrusion protein 2 | Cation antiporter | C00001891 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000615 | 0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000615 | 5 / 2 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000615 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001891 | 1 / 1 |
Q12794 | Hyaluronidase-1 | Enzyme | C00000615 | 1 / 2 |
Q16853 | Membrane primary amine oxidase | Enzyme | C00001408 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001916 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00000615 | 1 / 3 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001408 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000615 | 1 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00000615 | 0 / 0 |
P50225 | Sulfotransferase 1A1 | Enzyme | C00001408 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000615 | 3 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000615 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000615 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00001889 | 0 / 0 |
P35368 | Alpha-1B adrenergic receptor | Adrenergic receptor | C00001408 | 0 / 0 |
P35348 | Alpha-1A adrenergic receptor | Adrenergic receptor | C00001408 | 0 / 0 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00000615 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00000615 | 0 / 0 |
P48039 | Melatonin receptor type 1A | Melatonin receptor | C00001408 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00000615 | 1 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001891 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001876 | 7 / 3 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001924 | 0 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00000615 | 0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | C00000615 | 0 / 0 |
P50224 | Sulfotransferase 1A3/1A4 | Enzyme | C00001408 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000615 | 0 / 0 |
P00734 | Prothrombin | S1A | C00001916 | 4 / 2 |
Q96FL8 | Multidrug and toxin extrusion protein 1 | Cation antiporter | C00001891 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001408
C00001889
C00001891
C00001917
C00024663 C00027603 |
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00001408
C00001889
C00001891
C00001917
C00024663 C00027603 |
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001408
C00001889
C00001891
C00001917
C00024663 C00027603 |
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001408
C00001891
C00001899
C00001906
C00001917 C00024663 |
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00001889
C00001891
C00001917
C00024663
C00027603 |
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001408
C00001889
C00001917
C00024663
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00001408
C00001889
C00001917
C00024663
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001408
C00001917
C00024663
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001408
C00001889
C00001891
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00001889
C00001917
C00024663
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00001408
C00001917
C00024663
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00001408
C00001837
C00001889
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001917
C00024663
|
7122 | CLDN5, AWAL, BEC1, CPETRL1, TMVCF | claudin 5 |
C00001917
C00024663
|
1364 | CLDN4, CPE-R, CPER, CPETR, CPETR1, WBSCR8, hCPE-R | claudin 4 |
C00001917
C00024663
|
1365 | CLDN3, C7orf1, CPE-R2, CPETR2, HRVP1, RVP1 | claudin 3 |
C00001917
C00024663
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001917
C00024663
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001917
C00024663
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00001917
C00024663
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00001917
C00024663
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00001917
C00024663
|
6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 |
C00001917
C00024663
|
9075 | CLDN2 | claudin 2 |
C00001917
C00024663
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001899
C00001906
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00001889
C00027603
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001889
C00001891
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00001837
C00001889
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001917
C00024663
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001408
C00001837
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00001917
C00024663
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001408
C00001891
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001408
C00001889
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00001408
C00001889
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001408
C00001891
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001408
C00001889
|
100302129 | MIR1915, MIRN1915, hsa-mir-1915 | microRNA 1915 |
C00001889
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001408
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00001408
|
1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00001408
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00001408
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001408
|
2668 | GDNF, ATF1, ATF2, HFB1-GDNF, HSCR3 | glial cell derived neurotrophic factor |
C00001408
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00001408
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001408
|
664 | BNIP3, NIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
C00001408
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001408
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00001408
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00001408
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001408
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00001408
|
4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00001408
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00001408
|
4548 | MTR, HMAG, MS, cblG | 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) |
C00001408
|
5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00001408
|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00001837
|
5617 | PRL | prolactin |
C00001408
|
5998 | RGS3, C2PA, RGP3 | regulator of G-protein signaling 3 |
C00001408
|
6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00001408
|
6343 | SCT | secretin |
C00001408
|
6570 | SLC18A1, CGAT, VAT1, VMAT1 | solute carrier family 18 (vesicular monoamine transporter), member 1 |
C00001408
|
6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00001408
|
85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00001408
|
9016 | SLC25A14, BMCP1, UCP5 | solute carrier family 25 (mitochondrial carrier, brain), member 14 |
C00001408
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001408
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001408
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001408
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00001408
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001408
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001408
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001408
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00001408
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001837
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00001889
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001889
|
10550 | ARL6IP5, DERP11, GTRAP3-18, JWA, PRAF3, addicsin, hp22, jmx | ADP-ribosylation-like factor 6 interacting protein 5 |
C00001889
|
409 | ARRB2, ARB2, ARR2, BARR2 | arrestin, beta 2 |
C00001889
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00001889
|
10018 | BCL2L11, BAM, BIM, BOD | BCL2-like 11 (apoptosis facilitator) |
C00001889
|
8678 | BECN1, ATG6, VPS30, beclin1 | beclin 1, autophagy related |
C00001889
|
6355 | CCL8, HC14, MCP-2, MCP2, SCYA10, SCYA8 | chemokine (C-C motif) ligand 8 |
C00001889
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00001837
|
8824 | CES2, CE-2, CES2A1, PCE-2, iCE | carboxylesterase 2 (EC:3.1.1.1 3.1.1.84 3.1.1.56) |
C00001889
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001889
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00001889
|
1984 | EIF5A, EIF-5A, EIF5A1, eIF5AI | eukaryotic translation initiation factor 5A |
C00001889
|
2155 | F7, SPCA | coagulation factor VII (serum prothrombin conversion accelerator) (EC:3.4.21.21) |
C00001889
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00001889
|
2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00001889
|
3557 | IL1RN, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3, IL1F3, IL1RA, IRAP, MVCD4 | interleukin 1 receptor antagonist |
C00001889
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001889
|
8609 | KLF7, UKLF | Kruppel-like factor 7 (ubiquitous) |
C00001889
|
4010 | LMX1B, LMX1.2, NPS1 | LIM homeobox transcription factor 1, beta |
C00001889
|
406901 | MIR107, MIRN107, miR-107 | microRNA 107 |
C00001889
|
406921 | MIR132, MIRN132, miRNA132 | microRNA 132 |
C00001889
|
100302258 | MIR1469, MIRN1469, hsa-mir-1469 | microRNA 1469 |
C00001889
|
406938 | MIR146A, MIRN146, MIRN146A, miR-146a, miRNA146A | microRNA 146a |
C00001889
|
406942 | MIR150, MIRN150, miRNA150 | microRNA 150 |
C00001889
|
406947 | MIR155, MIRN155, miRNA155 | microRNA 155 |
C00001889
|
406949 | MIR15B, MIRN15B, hsa-mir-15b, miR-15b | microRNA 15b |
C00001889
|
406966 | MIR191, MIRN191, miR-191 | microRNA 191 |
C00001889
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001408
|
406991 | MIR21, MIRN21, hsa-mir-21, miR-21, miRNA21 | microRNA 21 |
C00001889
|
407006 | MIR221, MIRN221, miRNA221, mir-221 | microRNA 221 |
C00001889
|
407010 | MIR23A, MIRN23A, hsa-mir-23a, miRNA23A | microRNA 23a |
C00001889
|
407011 | MIR23B, MIRN23B, hsa-mir-23b, miRNA23B | microRNA 23b |
C00001889
|
407015 | MIR26A1, MIR26A, MIRN26A1 | microRNA 26a-1 |
C00001889
|
407017 | MIR26B, MIRN26B, hsa-mir-26b, miR-26b | microRNA 26b |
C00001889
|
407037 | MIR320A, MIRN320, MIRN320A, hsa-mir-320a | microRNA 320a |
C00001889
|
494335 | MIR423, MIRN423, hsa-mir-423 | microRNA 423 |
C00001889
|
693223 | MIR638, MIRN638, hsa-mir-638 | microRNA 638 |
C00001889
|
407056 | MIR99B, MIRN99B | microRNA 99b |
C00001889
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00001889
|
4814 | NINJ1, NIN1, NINJURIN | ninjurin 1 |
C00001889
|
4985 | OPRD1, OPRD | opioid receptor, delta 1 |
C00001889
|
4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00001889
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00001889
|
5443 | POMC, ACTH, CLIP, LPH, MSH, NPP, POC | proopiomelanocortin |
C00001889
|
84152 | PPP1R1B, DARPP-32, DARPP32 | protein phosphatase 1, regulatory (inhibitor) subunit 1B (EC:3.1.3.16) |
C00001889
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001889
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001889
|
6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00001889
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00001889
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00001889
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00001889
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001889
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00001889
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00001889
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00001889
|
7364 | UGT2B7, UDPGT_2B9, UDPGT2B7, UDPGTH2, UGT2B9 | UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17) |
C00001889
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00001891
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00001891
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001899
|
5150 | PDE7A, HCP1, PDE7 | phosphodiesterase 7A (EC:3.1.4.17) |
C00001899
|
6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 |
C00001899
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#600807 | Asthma, susceptibility to |
Q13093
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#606798 | Blepharospasm, benign essential |
P21918
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P18054
P84022 |
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#606703 | Dyskinesia, familial, with facial myokymia; fdfm |
O95622
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#180849 | Rubinstein-taybi syndrome 1; rsts1 |
Q92793
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00409 | Type II diabetes mellitus |
P49286
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00504 | Rubinstein-Taybi syndrome |
Q92793
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D012640 | Seizures |
C00001876
C00027603 C00001837 C00001408 C00001889 |
D002375 | Catalepsy |
C00001837
C00001408 C00001889 C00001899 |
D009336 | Necrosis |
C00001917
C00024663 C00001408 C00001889 |
D007022 | Hypotension |
C00001837
C00001408 C00001889 C00001899 |
D009369 | Neoplasms |
C00001917
C00024663 C00027603 |
D013610 | Tachycardia |
C00001837
C00001408 C00001889 |
D013375 | Substance Withdrawal Syndrome |
C00001837
C00001408 C00001889 |
D013035 | Spasm |
C00001837
C00001889 C00001899 |
D007024 | Hypotension, Orthostatic |
C00001837
C00001408 C00001889 |
D004409 | Dyskinesia, Drug-Induced |
C00001408
C00001889 C00001899 |
D018476 | Hypokinesia |
C00001837
C00001408 C00001889 |
D007008 | Hypokalemia |
C00001837
C00001408 C00001889 |
D001919 | Bradycardia |
C00001837
C00001889 C00001899 |
D006973 | Hypertension |
C00001837
C00001408 C00001889 |
D001145 | Arrhythmias, Cardiac |
C00001408
C00001889 C00001899 |
D006930 | Hyperalgesia |
C00001837
C00001408 C00001889 |
D003128 | COMA |
C00001837
C00001889 C00001899 |
D004244 | Dizziness |
C00001837
C00001889 C00001899 |
D003371 | Cough |
C00001837
C00001889 C00001891 |
D017202 | Myocardial Ischemia |
C00001408
C00001889 |
D003693 | Delirium |
C00001837
C00001889 |
D006940 | Hyperemia |
C00001889
C00001899 |
D003967 | Diarrhea |
C00001837
C00001889 |
D003248 | Constipation |
C00001837
C00001889 |
D006429 | Hemiplegia |
C00001889
C00001899 |
D005094 | Exophthalmos |
C00001889
C00001899 |
D004487 | Edema |
C00001889
C00001899 |
D002637 | Chest Pain |
C00001889
C00001899 |
D054537 | Atrioventricular Block |
C00001889
C00001899 |
D005076 | Exanthema |
C00001837
C00001889 |
D005334 | Fever |
C00001837
C00001889 |
D018487 | Ventricular Dysfunction, Left |
C00001408
C00001889 |
D005767 | Gastrointestinal Diseases |
C00001837
C00001889 |
D006261 | Headache |
C00001837
C00001889 |
D020301 | Vasospasm, Intracranial |
C00001408
C00001899 |
D018908 | Muscle Weakness |
C00001889
C00001899 |
D016171 | Torsades de Pointes |
C00001408
C00001899 |
D015878 | Mydriasis |
C00001889
C00001899 |
D010291 | Paresis |
C00001889
C00001899 |
D001049 | Apnea |
C00001837
C00001889 |
D000860 | Anoxia |
C00001837
C00001889 |
D012131 | Respiratory Insufficiency |
C00001889
C00001899 |
D013226 | Status Epilepticus |
C00001408
C00001889 |
D007674 | Kidney Diseases |
C00001837
C00001889 |
D012769 | Shock |
C00001408
C00001889 |
D011595 | Psychomotor Agitation |
C00001408
C00001889 |
D009120 | Muscle Cramp |
C00001837
C00001889 |
D009207 | Myoclonus |
C00001837
C00001889 |
D009325 | Nausea |
C00001837
C00001889 |
D009357 | Neonatal Abstinence Syndrome |
C00001837
C00001889 |
D009461 | Neurologic Manifestations |
C00001837
C00001899 |
D009846 | Oliguria |
C00001408
C00001889 |
D010146 | Pain |
C00001837
C00001889 |
D010149 | Pain, Postoperative |
C00001837
C00001889 |
D009422 | Nervous System Diseases |
C00001408
C00001889 |
D011297 | Prenatal Exposure Delayed Effects |
C00001837
C00001889 |
D011537 | Pruritus |
C00001837
C00001889 |
D019586 | Intracranial Hypertension |
C00001889
C00001899 |
D008133 | Long QT Syndrome |
C00001408
C00001899 |
D007859 | Learning Disorders |
C00001408
C00001889 |
D006948 | Hyperkinesis |
C00001408
C00001889 |
D006556 | Heroin Dependence |
C00001408
C00001889 |
D006331 | Heart Diseases |
C00001408
C00001889 |
D015746 | Abdominal Pain |
C00001837
C00001889 |
D046628 | Sphincter of Oddi Dysfunction |
C00001837
C00001889 |
D004417 | Dyspnea |
C00001408
C00001889 |
D019966 | Substance-Related Disorders |
C00001837
C00001889 |
D012878 | Skin Neoplasms |
C00001917
C00024663 |
D009374 | Neoplasms, Experimental |
C00001917
C00024663 |
D005317 | Fetal Growth Retardation |
C00001917
C00024663 |
D062787 | Drug Overdose |
C00001408
C00001889 |
D014839 | Vomiting |
C00001837
C00001889 |
D058186 | Acute Kidney Injury |
C00001408
C00001889 |
D004342 | Drug Hypersensitivity |
C00001408
C00001889 |
D020964 | Embryo Loss |
C00001917
C00024663 |
D001480 | Basal Ganglia Diseases |
C00001408
C00001889 |
D002389 | Catatonia |
C00001408
C00001889 |
D016055 | Urinary Retention |
C00001889
|
D002493 | Central Nervous System Diseases |
C00001408
|
D019970 | Cocaine-Related Disorders |
C00001408
|
D000788 | Angina Pectoris, Variant |
C00001408
|
D014806 | Vitamin B 12 Deficiency |
C00001837
|
D014517 | Ureteral Obstruction |
C00001837
|
D020521 | Stroke |
C00001837
|
D004802 | Eosinophilia |
C00001408
|
D006323 | Heart Arrest |
C00001408
|
D012891 | Sleep Apnea Syndromes |
C00001837
|
D006333 | Heart Failure |
C00001408
|
D012871 | Skin Diseases |
C00001837
|
D012216 | Rheumatic Diseases |
C00001837
|
D012185 | Retroperitoneal Fibrosis |
C00001837
|
D011776 | Pyuria |
C00001837
|
D020149 | Manganese Poisoning |
C00001408
|
D048629 | Micronuclei, Chromosome-Defective |
C00001408
|
D011695 | Purpura, Schoenlein-Henoch |
C00001837
|
D009205 | Myocarditis |
C00001408
|
D009410 | Nerve Degeneration |
C00001408
|
D010195 | Pancreatitis |
C00001837
|
D009771 | Obsessive-Compulsive Disorder |
C00001837
|
D010300 | Parkinson Disease |
C00001408
|
D020734 | Parkinsonian Disorders |
C00001408
|
D010547 | Persistent Fetal Circulation Syndrome |
C00001408
|
D007681 | Kidney Papillary Necrosis |
C00001837
|
D012127 | Respiratory Distress Syndrome, Newborn |
C00001408
|
D007680 | Kidney Neoplasms |
C00001837
|
D012770 | Shock, Cardiogenic |
C00001408
|
D012772 | Shock, Septic |
C00001408
|
D007232 | Infant, Newborn, Diseases |
C00001837
|
D013616 | Tachycardia, Sinus |
C00001408
|
D006967 | Hypersensitivity |
C00001837
|
D014202 | Tremor |
C00001408
|
D006330 | Heart Defects, Congenital |
C00001837
|
D005494 | Folic Acid Deficiency |
C00001837
|
D000014 | Abnormalities, Drug-Induced |
C00001889
|
D000142 | Acidosis, Respiratory |
C00001889
|
D056586 | Acute Chest Syndrome |
C00001889
|
D000219 | Adams-Stokes Syndrome |
C00001889
|
D000307 | Adrenal Gland Diseases |
C00001889
|
D019973 | Alcohol-Related Disorders |
C00001889
|
D000647 | Amnesia |
C00001889
|
D000707 | Anaphylaxis |
C00001889
|
D000855 | Anorexia |
C00001889
|
D001002 | Anuria |
C00001889
|
D001008 | Anxiety Disorders |
C00001889
|
D001281 | Atrial Fibrillation |
C00001889
|
D053159 | Dysuria |
C00001837
|
D001284 | Atrophy |
C00001889
|
D001416 | Back Pain |
C00001889
|
D001714 | Bipolar Disorder |
C00001889
|
D001927 | Brain Diseases |
C00001889
|
D002545 | Brain Ischemia |
C00001889
|
D002056 | Burns |
C00001889
|
D002194 | Capgras Syndrome |
C00001889
|
D002311 | Cardiomyopathy, Dilated |
C00001889
|
D004421 | Dystonia |
C00001837
|
D002764 | Cholecystitis |
C00001889
|
D002769 | Cholelithiasis |
C00001889
|
D002779 | Cholestasis |
C00001889
|
D003072 | Cognition Disorders |
C00001889
|
D003110 | Colonic Neoplasms |
C00001889
|
D003137 | Common Bile Duct Diseases |
C00001889
|
D020918 | Complex Regional Pain Syndromes |
C00001889
|
D003221 | Confusion |
C00001889
|
D003244 | Consciousness Disorders |
C00001889
|
D003327 | Coronary Disease |
C00001889
|
D055191 | Delayed Emergence from Anesthesia |
C00001889
|
D003731 | Dental Caries |
C00001889
|
D003919 | Diabetes Insipidus |
C00001889
|
D004108 | Dilatation, Pathologic |
C00001889
|
D004172 | Diplopia |
C00001889
|
D018450 | Disease Progression |
C00001889
|
D006970 | Disorders of Excessive Somnolence |
C00001889
|
D004213 | Dissociative Disorders |
C00001889
|
D056486 | Drug-Induced Liver Injury |
C00001889
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001889
|
D004415 | Dyspepsia |
C00001837
|
D004673 | Encephalomyelitis, Acute Disseminated |
C00001889
|
D004831 | Epilepsies, Myoclonic |
C00001889
|
D004827 | Epilepsy |
C00001889
|
D004830 | Epilepsy, Tonic-Clonic |
C00001889
|
D003875 | Drug Eruptions |
C00001837
|
D005157 | Facial Pain |
C00001889
|
D005221 | Fatigue |
C00001889
|
D005242 | Fecal Incontinence |
C00001889
|
D042882 | Gallstones |
C00001889
|
D006099 | Granuloma |
C00001889
|
D006212 | Hallucinations |
C00001889
|
D006417 | Hematuria |
C00001889
|
D004310 | Double Outlet Right Ventricle |
C00001837
|
D006470 | Hemorrhage |
C00001889
|
D006501 | Hepatic Encephalopathy |
C00001889
|
D006526 | Hepatitis C |
C00001889
|
D006560 | Herpes Labialis |
C00001889
|
D006606 | Hiccup |
C00001889
|
D006819 | Hyaline Membrane Disease |
C00001889
|
D006869 | Hydronephrosis |
C00001889
|
D006935 | Hypercapnia |
C00001889
|
D003866 | Depressive Disorder |
C00001837
|
D006941 | Hyperesthesia |
C00001889
|
D006987 | Hypesthesia |
C00001889
|
D007006 | Hypogonadism |
C00001889
|
D007018 | Hypopituitarism |
C00001889
|
D007035 | Hypothermia |
C00001889
|
D002534 | Hypoxia, Brain |
C00001889
|
D003490 | Cyanosis |
C00001837
|
D048949 | Labor Pain |
C00001889
|
D007826 | Laryngismus |
C00001889
|
D053609 | Lethargy |
C00001889
|
D017116 | Low Back Pain |
C00001889
|
D008175 | Lung Neoplasms |
C00001889
|
D008305 | Malignant Hyperthermia |
C00001889
|
D008569 | Memory Disorders |
C00001889
|
D015877 | Miosis |
C00001889
|
D009021 | Morphine Dependence |
C00001889
|
D009069 | Movement Disorders |
C00001889
|
D052016 | Mucositis |
C00001889
|
D009122 | Muscle Hypertonia |
C00001889
|
D009123 | Muscle Hypotonia |
C00001889
|
D009127 | Muscle Rigidity |
C00001889
|
D009128 | Muscle Spasticity |
C00001889
|
D003085 | Colic |
C00001837
|
D002295 | Carcinoma, Transitional Cell |
C00001837
|
D009203 | Myocardial Infarction |
C00001889
|
D015428 | Myocardial Reperfusion Injury |
C00001889
|
D009290 | Narcolepsy |
C00001889
|
D009437 | Neuralgia |
C00001889
|
D009436 | Neural Tube Defects |
C00001889
|
D020258 | Neurotoxicity Syndromes |
C00001889
|
D009759 | Nystagmus, Pathologic |
C00001889
|
D009293 | Opioid-Related Disorders |
C00001889
|
D010148 | Pain, Intractable |
C00001889
|
D010243 | Paralysis |
C00001889
|
D010259 | Paranoid Disorders |
C00001889
|
D020335 | Paraparesis |
C00001889
|
D020336 | Paraparesis, Spastic |
C00001889
|
D001660 | Biliary Tract Diseases |
C00001837
|
D010523 | Peripheral Nervous System Diseases |
C00001889
|
D010538 | Peritonitis |
C00001889
|
D010554 | Personality Disorders |
C00001889
|
D020250 | Postoperative Nausea and Vomiting |
C00001889
|
D011596 | Psychomotor Disorders |
C00001889
|
D011605 | Psychoses, Substance-Induced |
C00001889
|
D011654 | Pulmonary Edema |
C00001889
|
D011681 | Pupil Disorders |
C00001889
|
D012021 | Reflex, Abnormal |
C00001889
|
D001405 | Reflex, Babinski |
C00001889
|
D051437 | Renal Insufficiency |
C00001889
|
D015427 | Reperfusion Injury |
C00001889
|
D012120 | Respiration Disorders |
C00001889
|
D000740 | Anemia |
C00001837
|
D012206 | Rhabdomyolysis |
C00001889
|
D012585 | Sciatica |
C00001889
|
D020182 | Sleep Apnea, Central |
C00001889
|
D020181 | Sleep Apnea, Obstructive |
C00001889
|
D012892 | Sleep Deprivation |
C00001889
|
D012893 | Sleep Disorders |
C00001889
|
D013064 | Speech Disorders |
C00001889
|
D013117 | Spinal Cord Compression |
C00001889
|
D013118 | Spinal Cord Diseases |
C00001889
|
D013203 | Staphylococcal Infections |
C00001889
|
D019956 | Stereotypic Movement Disorder |
C00001889
|
D053608 | Stupor |
C00001889
|
D013705 | Temporomandibular Joint Disorders |
C00001889
|
D018677 | Tooth Injuries |
C00001889
|
D016388 | Tooth Loss |
C00001889
|
D014474 | Unconsciousness |
C00001889
|
D053201 | Urinary Bladder, Overactive |
C00001889
|
D014549 | Urinary Incontinence |
C00001889
|
D002303 | Cardiac Output, Low |
C00001408
|
D014555 | Urination Disorders |
C00001889
|
D018879 | Ventricular Premature Complexes |
C00001889
|
D014717 | Vertigo |
C00001889
|
D014786 | Vision Disorders |
C00001889
|
D015431 | Weight Loss |
C00001889
|
D014987 | Xerostomia |
C00001889
|
D003711 | Demyelinating Diseases |
C00001891
|
D005910 | Glioma |
C00001891
|
D015473 | Leukemia, Promyelocytic, Acute |
C00001891
|
D015458 | Leukemia, T-Cell |
C00001891
|
D001037 | Aphasia |
C00001899
|
D001157 | Arterial Occlusive Diseases |
C00001899
|
D001766 | Blindness |
C00001899
|
D002539 | Cerebral Arterial Diseases |
C00001899
|
D015862 | Choroid Diseases |
C00001899
|
D004414 | Dyspareunia |
C00001899
|
D007172 | Erectile Dysfunction |
C00001899
|
D005155 | Facial Nerve Diseases |
C00001899
|
D005158 | Facial Paralysis |
C00001899
|
D005355 | Fibrosis |
C00001899
|
D006319 | Hearing Loss, Sensorineural |
C00001899
|
D006406 | Hematoma |
C00001899
|
D006505 | Hepatitis |
C00001899
|
D006521 | Hepatitis, Chronic |
C00001899
|
D018783 | Impotence, Vasculogenic |
C00001899
|
D007238 | Infarction |
C00001899
|
D020766 | Intracranial Embolism |
C00001899
|
D007565 | Jaundice |
C00001899
|
D008103 | Liver Cirrhosis |
C00001899
|
D010411 | Penile Induration |
C00001899
|
D011183 | Postoperative Complications |
C00001899
|
D011317 | Priapism |
C00001899
|
D054138 | Sinus Arrest, Cardiac |
C00001899
|
D017180 | Tachycardia, Ventricular |
C00001899
|
D013927 | Thrombosis |
C00001899
|
D014693 | Ventricular Fibrillation |
C00001899
|
D000160 | Vestibulocochlear Nerve Diseases |
C00001899
|